NCT03761628View on ClinicalTrials.gov

Clinical Performance of a Vaginal Pessary (pHyph) in Vulvovaginal Candidiasis

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 7, 2019

Primary Completion Date

December 16, 2019

Study Completion Date

January 15, 2020

Conditions
Vulvovaginal Candidiasis
Interventions
DEVICE

pHyph generation I

A vaginal tablet for the treatment of VVC to be administered every 48 hours

Trial Locations (2)

Unknown

Hoftekliniken, Helsingborg

Annerokliniken, Hofterup

Sponsors

Lead Sponsor

Gedea Biotech AB
All Listed Sponsors
lead

Gedea Biotech AB

INDUSTRY